Arvinas, Inc. — Earnings Quality Grade D
ARVN · Healthcare
Significant concerns
Screening Summary
Management Signals
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO 1 days, change -7 days YoY
AR growth -82.5% vs revenue growth -0.3%
Revenue -0.3%, CFFO -5.6%. Cash follows revenue
Expense Quality
No material inventory
CapEx growth 5.6% vs revenue -0.3%. Normal
Insufficient data
Insufficient data
Cash Flow Quality
CFFO/NI = 3.39. Profits backed by cash
FCF is negative ($-0.3B)
Accruals ratio = 26.9%. Exceeds 10%
Cash $0.7B covers debt $0.0B
Balance Sheet Health
No goodwill. Clean balance sheet
Debt/EBITDA = -0.1x. Healthy
Other assets -53.1% vs revenue -0.3%. Normal
No write-off data
Acquisition Risk
FCF after acquisitions negative for 3 years
Small-cap context: A single acquisition on a small balance sheet can trip serial-acquirer logic.
No goodwill
Manipulation Score
Insufficient data
Portfolio monitoring
Monitor ARVN continuously
The full checks and model details are free to read. Use Watchlist to track your holdings; Pro adds automatic quarterly rescoring, risk-event email alerts, scans up to 50 tickers, and export workflows.
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25